The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...
The U.S. Preventive Services Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 ...
Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...
Having an understanding of the progression of lung cancer and the treatment methods helps the patients and their families to ...
The cancer has spread to lymph nodes near the opposite lung or in your neck. These cancers can’t be completely removed by surgery. Chemotherapy with radiation: Again, treatment depends on your ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...
In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Merck & Co Inc (NYSE:MRK) revealed that it would discontinue the clinical development programs for vibostolimab and ...